130

Providers

2000+

Products referenced

10+

active Delivery service providers

Supply Chain

Through a partnership with French Hospital/Clinic network and global Providers, we propose a wide range of Clinical grade material to facilitate your clinical Development.

    • Cell/Tissue from healthy Donors and Patients: adipose tissue, blood, leukaperesis, bone marrow,..

    • Full Qualification of human sample: donor eligibility/consents, serology, sterility,..

    • Various immortalized Cell lines

    • Qualified raw material at best price

Process and Analytical Development

From UpStream to DownStream Process Development, our tailored approach bring robustness, cost-control and time-saving to your process.

    • ADHERENT and Non-ADHERENT Cell types
    • PRIMARY or ENGINEERED Cell line

    • Strong experience in CELL BIOLOGY

Our SCIENTIFIC approach combined to our REGULATORY expertise brings to your product the best chance for a seamless scale-up and GMP Production.

1mL - 50L+

Culture volume capabilities

50+

in-house analytical assays

20+

Process Development Projects

5 & 10

class-B cleanrooms and R&D/QC labs

20+

GMP batches produced

100+

Instrumentations & Technologies

GMP Manufacturing & Cell Banking

Our experienced Production and QC Teams are working daily in a state-of-the-art facility authorized by the National French regulatory Agency (ANSM). From Technology Transfer to GMP Manufacturing, we support your projects with transparency and collaboration to find a solution to every Manufacturing challenge. 

    • AUTOLOGOUS & ALLOGENEIC programs
    • Compliance with EMA and FDA
    • Double language SMQ DOCUMENTATION
    • TIME-saving focused

QC & Regulatory Support

Our high skilled Quality Assurance (QA) team supported by a robust Quality Management System (QMS), has all the required procedures in place for CELL BANKING, DRUG SUBSTANCE batch release and for DRUG PRODUCT batch certification for use in clinical trials.

Combined with stringent QC PROCEDURES, you will ensure a complete control and traceability of the Manufacturing and Release of your Cell-based product.

Compliance with EMA and FDA

10+

QC Technicians & Engineers

20+

IMPD co-writing

500+

SMQ Documentations

10+

French Hospitals

1000+

patients identified for multiple therapeutic indications 

Patient Access

Because the PATIENT is at the heart of our industry, we are concerned with facilitating access to the next advanced therapies.
Our medico-economic understanding of the healthcare industry has enabled us to establish privileged relationships with leading PHYSICIANS who share our ambitions.

Let’s connect with the medical fields most sensitive to cell-based therapies, to offer the access patients in:

    • IMMUNO-ONCOLOGY
    • REGENRATIVE MEDICINE
    • AUTO-IMMUNITY

Have a project you would like to share ?